Tailor Made Compounding: The 2020 Guilty Plea and Why It Still Comes Up
Tailor Made Compounding, a Kentucky compounding pharmacy, pleaded guilty in October 2020 over the distribution of unapproved new drugs between 2018 and 2020, with $1,788,906.82 in forfeiture, per the U.S. Department of Justice; owner Jeremy Delk pleaded guilty to unlicensed wholesale distribution. Per industry reports, it is an early, frequently referenced case in coverage of the 2025-2026 enforcement wave.
What Happened to Tailor Made Compounding?
Per the October 2020 DOJ announcement, Tailor Made Compounding entered a guilty plea related to distributing unapproved new drugs between 2018 and 2020, with $1,788,906.82 in forfeiture, and owner Jeremy Delk pleaded guilty to unlicensed wholesale distribution.
The DOJ's account names the distributed compounds: BPC-157, CJC-1295, ipamorelin, MK-677, and others. Those names appear here as facts of the legal case: the charge was distributing them as unapproved new drugs, outside any approved framework.
Why Does a 2020 Case Matter in 2026?
Because it showed, years before the current wave, that peptide distribution outside the approved-drug framework could end in federal criminal pleas and seven-figure forfeiture, not just warning letters. Per industry reports, it is an early, frequently referenced case in coverage of the 2025-2026 wave. Read against it, the criminal prosecution of Paradigm Peptides (guilty pleas December 2025) and the reported June 2025 enforcement action against Amino Asylum look less like a sudden change of policy and more like an escalation of a pattern visible years earlier.
Is Tailor Made Compounding Still Operating?
The distribution operation described in the case ended with it. This entry exists in the log as an early reference point for the current enforcement timeline.
Where Researchers Go From Here
The alternatives below are stores in the AntiGravity brand network (which operates Amino Axiom), with published certificates of analysis and live price data tracked on this site.
Dated Timeline
- 2018
Start of the 2018-2020 distribution period covered by the later guilty plea, per the DOJ.
Source: DOJ, U.S. Attorney’s Office, E.D. Kentucky (press release) - Oct 2020
Tailor Made Compounding pleads guilty over distribution of unapproved new drugs (2018-2020), with $1,788,906.82 in forfeiture; owner Jeremy Delk pleads guilty to unlicensed wholesale distribution.
Source: DOJ, U.S. Attorney’s Office, E.D. Kentucky (press release)
Alternatives That Are Open
The stores below are part of the AntiGravity brand network, which operates Amino Axiom. That relationship is why they are listed here, and why the claims stay observable: each one is open, publishes certificates of analysis, and has its catalog and pricing tracked live on this site. All compounds are sold for research purposes only.
Widest peptide selection with third-party COA verification on every batch. The standard others are measured against.
Wellness-forward research peptides with a longevity-leaning catalog and third-party COA verification on every batch.
Research compounds with a minimalist catalog and independent batch verification.
Disclosure: Outbound links to vendor sites are referral/affiliate links. Amino Axiom may earn a commission on purchases made through them.
Sources
Related reading
- FDA peptide enforcement timeline (2020-2026)
- What Happened to Paradigm Peptides? The Criminal Case, Explained
- Is Strate Labs Closing? The July 2026 Shutdown and the ITC Paper Trail
- Amino Asylum: The Reported June 2025 Raid, and Is It Coming Back?
- Peptide Sciences Shut Down: Refunds, Store Credit, and Pending Orders
- Science.bio Is Permanently Closed: The January 2026 Announcement
- PurchasePeptides.com Is Gone: Offline With No Announcement
- AffordablePeptides.com Was Taken Down by Its Own Website Platform
- What Happened to Rats Army? Warning Letter, Conviction, and Debarment